CYTOPENIA
Clinical trials for CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CYTOPENIA trials appear
Sign up with your email to follow new studies for CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for MDS anemia: experimental drug enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called elritercept (KER-050) in 160 adults with a bone marrow condition called myelodysplastic syndromes (MDS) who have anemia. The main goals are to check the drug's safety and how well people tolerate different doses. Researchers will also …
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New drug may boost blood cell recovery in kids with bone marrow failure
Disease control Recruiting nowThis study tests whether giving emapalumab early can help children with aplastic anemia recover their blood cell counts within six weeks. About 35 children with newly diagnosed severe aplastic anemia will receive the drug before standard treatments. The goal is to see if this app…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
New hope for CAR T-Cell recovery: emapalumab trial targets lingering low blood counts
Disease control Recruiting nowThis study tests whether emapalumab can safely help people with lymphoma whose blood cell counts stay dangerously low after CAR T-cell therapy. About 32 adults who have already received standard CAR T-cell treatment will take part. The goal is to see if this drug can restore norm…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Could early treatment stop a Pre-Cancer blood disorder?
Disease control Recruiting nowThis study looks at whether giving an oral drug early to people with a high-risk blood condition (CCUS) is safe and practical. CCUS can sometimes turn into blood cancer. Participants can choose to take the drug or just be watched. The goal is to see if early action helps control …
Matched conditions: CYTOPENIA
Phase: EARLY_PHASE1 • Sponsor: Lachelle D. Weeks, MD, PhD • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
Blood test could end painful bone marrow biopsies for MDS patients
Diagnosis Recruiting nowThis study is developing a new blood test to diagnose a bone marrow disorder called MDS. Currently, diagnosis requires a painful bone marrow biopsy, but this test aims to use a simple blood sample instead. The study will enroll 1500 adults with low blood counts to see if the bloo…
Matched conditions: CYTOPENIA
Sponsor: Weizmann Institute of Science • Aim: Diagnosis
Last updated May 26, 2026 07:04 UTC
-
Can a simple genetic test catch blood cancers before they start?
Knowledge-focused Recruiting nowThis study uses advanced genetic testing (next generation sequencing) to look for early warning signs of pre-myeloid cancers and bone marrow failure in 2000 people. Participants have certain blood abnormalities or genetic markers that may increase their risk. The goal is to bette…
Matched conditions: CYTOPENIA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC